1-3 of 3
Eric Chan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CRISPR/Cas9 Genome Editing to Treat Sickle Cell Disease and B-Thalassemia: Re-Creating Genetic Variants to Upregulate Fetal Hemoglobin Appear Well-Tolerated, Effective and Durable.

Michelle I. Lin, PhD, Elizabeth Paik, PhD, Bibhu Mishra, PhD, David Burkhardt, Andrew Kernytsky, PhD, Michael Pettiglio, Yi-Shan Chen, Kaleigh Tomkinson, Amanda Woo, Mauricio Cortes, PhD, Siyuan Tan, PhD, Todd D Borland, BS, Lawrence Klein, PhD, Angela Yen, PhD, Sudipta Mahajan, Eric Chan, PhD, Brenda Eustace, PhD, Matthew Porteus, MD PhD, Tirtha Chakraborty, PhD, Chad Cowan, Rodger Novak, MD, Ante Lundberg, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 284.
https://doi.org/10.1182/blood.V130.Suppl_1.284.284
Published: 2017
Journal Articles

A Novel Ribonuclease-Based Immunotoxin Comprising Quadruple Ranpirnase (Rap) Site-Specifically Conjugated to An Anti-CD22 IgG Showing Potent Anti-Lymphoma Activity.

Edmund A Rossi, PhD, Eric Chan, Pankaj Gupta, Ph.D, David M. Goldenberg, ScD, MD, Chien-Hsing Chang, PhD
Journal: Blood
Blood (2009) 114 (22): 3721.
https://doi.org/10.1182/blood.V114.22.3721.3721
Published: 2009
Journal Articles

Clonal Genetic Progression in t(14;18)-Positive Follicular Lymphomas.

Francesco d’Amore, MD, Eric Chan, BS, Xiao Li, PhD, Javeed Iqbal, PhD, Simon Sherman, PhD, Michelle M. Hess, MS, Warren G. Sanger, PhD, Wing C. Chan, MD, Bhavana J. Dave, PhD
Journal: Blood
Blood (2005) 106 (11): 995.
https://doi.org/10.1182/blood.V106.11.995.995
Published: 2005